- Home
- XGN vs NEN Comparison
XGN vs NEN Comparison
Compare XGN & NEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XGN
- NEN
- Stock Information
- Founded
- XGN 2002
- NEN 1977
- Country
- XGN United States
- NEN United States
- Employees
- XGN N/A
- NEN N/A
- Industry
- XGN Medical Specialities
- NEN Building operators
- Sector
- XGN Health Care
- NEN Real Estate
- Exchange
- XGN Nasdaq
- NEN Nasdaq
- Market Cap
- XGN 253.9M
- NEN 250.0M
- IPO Year
- XGN 2019
- NEN N/A
- Fundamental
- Price
- XGN $10.77
- NEN $71.06
- Analyst Decision
- XGN Strong Buy
- NEN
- Analyst Count
- XGN 6
- NEN 0
- Target Price
- XGN $12.83
- NEN N/A
- AVG Volume (30 Days)
- XGN 239.9K
- NEN 1.4K
- Earning Date
- XGN 11-04-2025
- NEN 01-01-0001
- Dividend Yield
- XGN N/A
- NEN 6.75%
- EPS Growth
- XGN N/A
- NEN 34.86
- EPS
- XGN N/A
- NEN 4.59
- Revenue
- XGN $63,599,000.00
- NEN $83,884,808.00
- Revenue This Year
- XGN $22.50
- NEN N/A
- Revenue Next Year
- XGN $14.75
- NEN N/A
- P/E Ratio
- XGN N/A
- NEN $15.36
- Revenue Growth
- XGN 14.08
- NEN 4.96
- 52 Week Low
- XGN $2.38
- NEN $68.41
- 52 Week High
- XGN $12.23
- NEN $84.00
- Technical
- Relative Strength Index (RSI)
- XGN 39.96
- NEN 48.31
- Support Level
- XGN $11.58
- NEN $69.08
- Resistance Level
- XGN $11.92
- NEN $71.00
- Average True Range (ATR)
- XGN 0.33
- NEN 0.59
- MACD
- XGN -0.13
- NEN -0.03
- Stochastic Oscillator
- XGN 15.61
- NEN 67.86
About XGN Exagen Inc.
Exagen Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases. It currently markets ten testing products under its Avise brand to provide an accurate, timely, and differential diagnosis and to optimize the treatment of ARDs. It markets and sells solutions to community rheumatologists.
About NEN New England Realty Associates Limited Partnership Depositary Receipts Evidencing Units of Limited Partnership
New England Realty Associates LP is engaged in the business of acquiring, developing, holding for investment, operating and selling real estate. The Partnership owns and operates various residential apartments, condominium units and commercial properties located in Massachusetts and New Hampshire. The company generates revenue from rental income from residential and commercial properties recognized over the term of the related lease. The long-term goals of the Partnership are to manage, rent and improve its properties and to acquire additional properties with income and capital appreciation potential as suitable opportunities arise.